Lisa Maier
Lisa Maier
EMBL Heidelberg
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Extensive impact of non-antibiotic drugs on human gut bacteria
L Maier, M Pruteanu, M Kuhn, G Zeller, A Telzerow, EE Anderson, ...
Nature 555 (7698), 623-628, 2018
Salt-responsive gut commensal modulates TH 17 axis and disease
N Wilck, MG Matus, SM Kearney, SW Olesen, K Forslund, ...
Nature 551 (7682), 585-589, 2017
Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae
B Stecher, R Denzler, L Maier, F Bernet, MJ Sanders, DJ Pickard, ...
Proceedings of the National Academy of Sciences 109 (4), 1269-1274, 2012
'Blooming'in the gut: how dysbiosis might contribute to pathogen evolution
B Stecher, L Maier, WD Hardt
Nature Reviews Microbiology 11 (4), 277-284, 2013
Stabilization of cooperative virulence by the expression of an avirulent phenotype
M Diard, V Garcia, L Maier, MNP Remus-Emsermann, RR Regoes, ...
Nature 494 (7437), 353-356, 2013
Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM.
G Xia, L Maier, P Sanchez-Carballo, M Li, M Otto, O Holst, A Peschel
J Biol Chem. 2010, 2010
Microbiota-Derived Hydrogen Fuels Salmonella Typhimurium Invasion of the Gut Ecosystem
L Maier, R Vyas, CD Cordova, H Lindsay, TSB Schmidt, S Brugiroux, ...
Cell host & microbe 14 (6), 641-651, 2013
Granulocytes impose a tight bottleneck upon the gut luminal pathogen population during Salmonella typhimurium colitis
L Maier, M Diard, ME Sellin, ES Chouffane, K Trautwein-Weidner, ...
PLoS Pathog 10 (12), e1004557, 2014
Systematically investigating the impact of medication on the gut microbiome
L Maier, A Typas
Current opinion in microbiology 39, 128-135, 2017
Escherichia coli limits Salmonella Typhimurium infections after diet shifts and fat-mediated microbiota perturbation in mice
SY Wotzka, M Kreuzer, L Maier, M Arnoldini, BD Nguyen, AO Brachmann, ...
Nature microbiology 4 (12), 2164-2174, 2019
Salmonella Typhimurium strain ATCC14028 requires H 2-hydrogenases for growth in the gut, but not at systemic sites
L Maier, M Barthel, B Stecher, RJ Maier, JS Gunn, WD Hardt
PloS one 9 (10), e110187, 2014
Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice
B Periaswamy, L Maier, V Vishwakarma, E Slack, M Kremer, ...
PLoS One 7 (9), e45433, 2012
Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral …
K Endt, L Maier, R Käppeli, M Barthel, B Misselwitz, M Kremer, WD Hardt
Antimicrobial agents and chemotherapy 56 (5), 2295-2304, 2012
Microbiota stability in healthy individuals after single-dose lactulose challenge—A randomized controlled study
SY Wotzka, M Kreuzer, L Maier, M Zünd, M Schlumberger, B Nguyen, ...
PloS one 13 (10), e0206214, 2018
Dissecting the collateral damage of antibiotics on gut microbes
L Maier, CV Goemans, M Pruteanu, J Wirbel, M Kuhn, E Cacace, ...
BioRxiv, 2020
Repurposing compounds for the treatment of infections and for modulating the composition of the gut microbiome
M Pruteanu, L Maier, M Kuhn, P Bork, A Typas, KR Patil, G Zeller
US Patent App. 16/966,307, 2020
In-vitro model of the human gut microbiome and uses thereof in the analysis of the impact of xenobiotics
M Tramontano, KR Patil, M Klünemann, M Pruteanu, L Maier, M Kuhn, ...
US Patent App. 16/966,322, 2020
Komplexe Wechselwirkungen zwischen Arzneimitteln und dem Mikrobiom
L Maier
BIOspektrum 25 (7), 707-710, 2019
Correction: Granulocytes Impose a Tight Bottleneck upon the Gut Luminal Pathogen Population during Salmonella Typhimurium Colitis ((2015), 11, 7)
L Maier, M Diard, ME Sellin, ES Chouffane, K Trautwein-Weidner, ...
The role of the intestinal microbiota in enteric Salmonella typhimurium infection
LB Maier
ETH Zurich, 2013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20